GlobeNewswire

Solid Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
10/11/2026
CHARLESTOWN, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
VivoSim Labs to Showcase Multiparametric Human 3D Tissue Safety Data at the American College of Toxicology (ACT) 47th Annual Meeting
10/11/2026
Company to feature two scientific poster presentations highlighting that its multiparametric approach delivers superior predictive power for both its DILI risk stratification and gastrointestinal toxicity profiling [...]
Novartis ranks first place in 2026 Access to Medicine Index
10/11/2026
Novartis retains first place ranking among 20 sector peers for efforts to improve access to medicines First company to achieve No. 1 rank across all Technical Areas since Index began in 2008, achieving R&D score [...]
Aradigm appoints Tim Wentworth to board of directors
10/11/2026
Former CEO of Walgreens Boots Alliance and Express Scripts brings expertise in high-cost drug management, patient pharmacy care, supply chain and purchaser economics as Aradigm scales its cell and gene therapy platform [...]
Spyre Therapeutics to Participate in Upcoming Investor Conferences
10/11/2026
WALTHAM, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology [...]
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members
10/11/2026
Two major federal awards totaling nearly $16.8 million will support research over a period of up to five years, including research examining how SilverCloud by Amwell, the digital cognitive behavioral therapy program on [...]
Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London
10/11/2026
CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]
MannKind to Participate in Upcoming Investor Conferences
10/11/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced that Chief Executive Officer, Michael Castagna, and Chief Financial Officer, Chris [...]
Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King
10/11/2026
KANSAS CITY, Kan., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop next-generation [...]
Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference
10/11/2026
BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in a fireside [...]
TaiMed Biologics Announces Publication in The Lancet HIV of Phase 1b/2a Study of Long-Acting Dual-Antibody HIV Maintenance Regimen TMB-365/TMB-380
10/11/2026
Further analysis of previously announced Phase 2a results showed 94% of evaluable participants maintained viral suppression through 24 weeks, with no confirmed virologic failures Study evaluated TMB-365/TMB-380 without [...]
Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a Corporate Update
10/11/2026
Dosed first patient in TEMPO-1 registrational study of sutantatug envedotin (CRB-701) in patients with 2L+ oropharyngeal cancer Reported topline data from the CANYON-1 Phase 1b obesity study of CRB-913 demonstrating [...]
Paragon Genomics and Intelliseq Partner to Accelerate High-Throughput Pharmacogenomic Profiling
10/11/2026
Learn more about the unique PGx capabilities enabled by the collaboration in an Innovation Spotlight presentation at AMP 2026 on November 13, 2026 FREMONT, Calif. and MURRIETA, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
AchieveRx Reports Third Quarter 2026 Financial Results and Provides Business Updates
10/11/2026
Launched new corporate brand as AchieveRx, The Quit Company (Nasdaq: QUIT) Presented 52-week ORCA-OL data at the CHEST 2026 Annual Meeting showing that nearly one in three adults still smoking or vaping after a [...]
Krystal Biotech to Present at Upcoming Investor Conferences
10/11/2026
PITTSBURGH, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that management will take part in fireside chats and host investor meetings at the following conferences [...]
TETmedical Appoints Dr. Hooman Kamel and Dr. Evan Gerber as Medical Advisors
10/11/2026
Leading Vascular Neurologist and Emergency Physician Bring Front-Line Stroke Expertise as TETmedical Advances NSE-FAST® Through Its Pivotal Study FAIR HAVEN, N.J. and ITHACA, N.Y., Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
Rakovina Therapeutics Secures Exclusive Worldwide Licence to Artemis.AI™ Platform for DNA-Damage Response Oncology Drug Discovery
10/11/2026
Perpetual, royalty-free, exclusive licence for DDR oncology including all future platform improvements, in exchange for C$1.0 million in Rakovina shares VANCOUVER, British Columbia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
Franciscan Health and Ossium Health Perform World's First Organ Donor Bone Marrow Transplant for Non-Malignant Disease
10/11/2026
Patient with severe aplastic anemia successfully transplanted, expanding access to a stem cell source long considered optimal for non-malignant conditions INDIANAPOLIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Franciscan [...]
Nu-Tek BioSciences Successfully Completes ISO 9001 Certification Review, Reinforcing Commitment to Raw Material Quality
10/11/2026
Continuous ISO 9001 certification reinforces Nu-Tek’s focus on quality management, manufacturing consistency, and the supplier assurance priorities of biopharmaceutical customers MINNETONKA, Minn., Nov. 10, 2026 (GLOBE [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum